Junji Yodoi

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Thioredoxin attenuates ischemia-reperfusion-induced pressure ulcer formation by enhancing HIF-1α/BNIP3-dependent mitophagy and suppressing MAPK/NF-κB signaling.

Thioredoxin attenuates ischemia-reperfusion-induced pressure ulcer formation by enhancing HIF-1α/BNIP3-dependent mitophagy and suppressing MAPK/NF-κB signaling.

Journal: Archives of biochemistry and biophysics

Published: December 06, 2025

Thioredoxin improves contact dermatitis through an anti-inflammatory mechanism different from glucocorticoids.

Thioredoxin improves contact dermatitis through an anti-inflammatory mechanism different from glucocorticoids.

Journal: Free radical research

Published: July 18, 2025

Retraction: Nitric Oxide Induces Hypoxia-inducible Factor 1 Activation That Is Dependent on MAPK and Phosphatidylinositol 3-Kinase Signaling.

Retraction: Nitric Oxide Induces Hypoxia-inducible Factor 1 Activation That Is Dependent on MAPK and Phosphatidylinositol 3-Kinase Signaling.

Journal: The Journal of biological chemistry

Published: July 06, 2025

Prolonged depletion of renal tubular thioredoxin following severe acute kidney injury is associated with transition to chronic kidney disease via G2/M cell cycle arrest.

Prolonged depletion of renal tubular thioredoxin following severe acute kidney injury is associated with transition to chronic kidney disease via G2/M cell cycle arrest.

Journal: Biochemical and biophysical research communications

Published: July 18, 2024

TXM-CB13 Improves the Intestinal Mucosal Barrier and Alleviates Colitis by Inhibiting the ROS/TXNIP/TRX/NLRP3 and TLR4/MyD88/NF-κB/NLRP3 Pathways.

TXM-CB13 Improves the Intestinal Mucosal Barrier and Alleviates Colitis by Inhibiting the ROS/TXNIP/TRX/NLRP3 and TLR4/MyD88/NF-κB/NLRP3 Pathways.

Journal: Inflammation

Published: May 31, 2024

Redoxisome Update: TRX and TXNIP/TBP2-Dependent Regulation of NLRP-1/NLRP-3 Inflammasome.

Redoxisome Update: TRX and TXNIP/TBP2-Dependent Regulation of NLRP-1/NLRP-3 Inflammasome.

Journal: Antioxidants & redox signaling

Published: February 22, 2024

Geranylgeranylacetone Ameliorates Skin Inflammation by Regulating and Inducing Thioredoxin via the Thioredoxin Redox System.

Geranylgeranylacetone Ameliorates Skin Inflammation by Regulating and Inducing Thioredoxin via the Thioredoxin Redox System.

Journal: Antioxidants (Basel, Switzerland)

Published: June 16, 2023

Recombinant human thioredoxin ameliorates imiquimod-induced psoriasis-like dermatitis in mice.

Recombinant human thioredoxin ameliorates imiquimod-induced psoriasis-like dermatitis in mice.

Journal: Journal of dermatological science

Published: May 31, 2023

Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases.

Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases.

Journal: Frontiers in immunology

Published: February 24, 2022

Prospect of thioredoxin as a possibly effective tool to combat OSAHS.

Prospect of thioredoxin as a possibly effective tool to combat OSAHS.

Journal: Sleep & breathing = Schlaf & Atmung

Published: October 01, 2021

Urinary Thioredoxin as a Biomarker of Renal Redox Dysregulation and a Companion Diagnostic to Identify Responders to Redox-Modulating Therapeutics.

Urinary Thioredoxin as a Biomarker of Renal Redox Dysregulation and a Companion Diagnostic to Identify Responders to Redox-Modulating Therapeutics.

Journal: Antioxidants & redox signaling

Published: September 20, 2021

Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD.

Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD.

Journal: Antioxidants (Basel, Switzerland)

Published: August 07, 2021

Showing 1-12 of 43

Last Updated: 09/26/2026